146 related articles for article (PubMed ID: 37964449)
1. Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing.
Liu PH; Nair RG; Skinner CS; Murphy CC; Kim EJ; Ortiz C; Wang L; Hu E; Lykken JM; Levin TR; Green BB; Hahn EE; Santini N; Halm EA
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):215-223. PubMed ID: 37964449
[TBL] [Abstract][Full Text] [Related]
2. Disparities in Colorectal Cancer Screening Practices in a Midwest Urban Safety-Net Healthcare System.
Elangovan A; Skeans J; Lalani I; Ullah F; Roy A; Kaelber DC; Cooper GS; Sandhu DS
Dig Dis Sci; 2021 Aug; 66(8):2585-2594. PubMed ID: 32816217
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Colorectal Cancer Screening Modality Among Newly Age-Eligible Medicaid Enrollees.
Mojica CM; Lind B; Gu Y; Coronado GD; Davis MM
Am J Prev Med; 2021 Jan; 60(1):72-79. PubMed ID: 33223363
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
[TBL] [Abstract][Full Text] [Related]
5. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
6. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.
Martin J; Halm EA; Tiro JA; Merchant Z; Balasubramanian BA; McCallister K; Sanders JM; Ahn C; Bishop WP; Singal AG
Am J Med; 2017 Jan; 130(1):93.e1-93.e7. PubMed ID: 27591183
[TBL] [Abstract][Full Text] [Related]
7. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
[TBL] [Abstract][Full Text] [Related]
8. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
9. Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial.
Robertson DJ; Dominitz JA; Beed A; Boardman KD; Del Curto BJ; Guarino PD; Imperiale TF; LaCasse A; Larson MF; Gupta S; Lieberman D; Planeta B; Shaukat A; Sultan S; Menees SB; Saini SD; Schoenfeld P; Goebel S; von Rosenvinge EC; Baffy G; Halasz I; Pedrosa MC; Kahng LS; Cassim R; Greer KB; Kinnard MF; Bhatt DB; Dunbar KB; Harford WV; Mengshol JA; Olson JE; Patel SG; Antaki F; Fisher DA; Sullivan BA; Lenza C; Prajapati DN; Wong H; Beyth R; Lieb JG; Manlolo J; Ona FV; Cole RA; Khalaf N; Kahi CJ; Kohli DR; Rai T; Sharma P; Anastasiou J; Hagedorn C; Fernando RS; Jackson CS; Jamal MM; Lee RH; Merchant F; May FP; Pisegna JR; Omer E; Parajuli D; Said A; Nguyen TD; Tombazzi CR; Feldman PA; Jacob L; Koppelman RN; Lehenbauer KP; Desai DS; Madhoun MF; Tierney WM; Ho MQ; Hockman HJ; Lopez C; Carter Paulson E; Tobi M; Pinillos HL; Young M; Ho NC; Mascarenhas R; Promrat K; Mutha PR; Pandak WM; Shah T; Schubert M; Pancotto FS; Gawron AJ; Underwood AE; Ho SB; Magno-Pagatzaurtundua P; Toro DH; Beymer CH; Kaz AM; Elwing J; Gill JA; Goldsmith SF; Yao MD; Protiva P; Pohl H; Kyriakides T;
JAMA Netw Open; 2023 Jul; 6(7):e2321730. PubMed ID: 37432690
[TBL] [Abstract][Full Text] [Related]
10. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
11. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
[TBL] [Abstract][Full Text] [Related]
12. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667
[TBL] [Abstract][Full Text] [Related]
13. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
14. Financial Incentives to Increase Colorectal Cancer Screening Uptake and Decrease Disparities: A Randomized Clinical Trial.
Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Kimbel KJ; Kullgren JT; Meenan RT; Vernon SW
JAMA Netw Open; 2019 Jul; 2(7):e196570. PubMed ID: 31276178
[TBL] [Abstract][Full Text] [Related]
15. Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models.
Baldwin LM; Coronado GD; West II; Schwartz MR; Meenan RT; Vollmer WM; Petrik AF; Shapiro JA; Kulkarni-Sharma YR; Green BB
Cancer; 2022 Jan; 128(2):410-418. PubMed ID: 34586630
[TBL] [Abstract][Full Text] [Related]
16. Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016.
Almansoori A; Alzaabi M; Alketbi L
BMC Cancer; 2021 Aug; 21(1):897. PubMed ID: 34362343
[TBL] [Abstract][Full Text] [Related]
17. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
[TBL] [Abstract][Full Text] [Related]
18. Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study.
Shin HY; Suh M; Choi KS; Hwang SH; Jun JK; Han DS; Lee YK; Oh JH; Lee CW; Lee DH
BMC Cancer; 2018 Apr; 18(1):365. PubMed ID: 29609647
[TBL] [Abstract][Full Text] [Related]
19. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.
Li JB; Ke KJ; Zhang WL; Wang LY; Wu YP; Weng F; Tian H; Qiu ZY; Li Y; Lin SY; Ye MX; Ou QJ; Gong CH; Lu ZH; Pan ZZ; Wan DS; Peng JH; Fang YJ
Cancer Med; 2022 Nov; 11(22):4321-4331. PubMed ID: 35441812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
